Updated daily. Deadlines shown in UTC; confirm on the official notice.
647 results · page 2 of 27
Bureau of International Labor Affairs
Questions regarding this Funding Opportunity Announcement (FOA) may be emailed to OGM_ILAB@dol.gov.
Bureau of International Labor Affairs
Questions regarding this Funding Opportunity Announcement (FOA) may be emailed to OGM_ILAB@dol.gov.
National Institute of Food and Agriculture
The goal of the FADI-EDEN program, under assistance listing 10.304, is to support CES’s ability to maximize the resilience of the U.S. food and agriculture sector to biosecurity risks, weather events and disasters, cyber threats, and other shocks through the Extension Disaster Education Network (EDEN). EDEN is a national, collaborative network of CES professionals who are dedicated to improved all-hazards management of domestic disasters. EDEN supports all-hazards capacity-building efforts for peer CES professionals so that they are prepared for and skilled in directly providing education and technical assistance to farmers, youth and families, small businesses, and communities. The FADI-EDEN program provides coordination support and administrative leadership to EDEN so that it can achieve its mission.
National Institute of Food and Agriculture
The purpose of ARME, Assistance Listing 10.520, is to educate agricultural producers about the full range of risk management activities. These activities include futures, options, agricultural trade options, crop insurance, cash forward contracting, debt reduction, production diversification, marketing plans and tactics, farm resources risk reduction, and other appropriate risk management strategies. The program authority specifies that special emphasis shall be placed on farm viability and risk management strategies (including farm financial benchmarking, business planning and technical assistance, market assessment, transfer and succession planning, and crop insurance participation), education, and outreach specifically focused at farmers and ranchers in Section 133 of the Agriculture Risk Protection Act of 2000 (7 U.S.C. 1524 (a)).
Animal and Plant Health Inspection Service
This funding opportunity is provided to carry out the provisions described in Section 7721 of the Plant Protection Act. Through the PPA 7721 program, APHIS provides funds to support projects that protect specialty crops, nursery systems, forestry, other agricultural production systems, and natural resources from harmful and invasive plant pests and pathogens. Additional details about the program are available on the PPDMDPP website. APHIS will make available up to $90,000,000 in funds to support PPA 7721 projects in Fiscal Year 2027 (FY 2027), with at least $73 million anticipated to be available for PPA 7721 PPDMDPP. APHIS will consider suggestions that clearly and directly support the objectives and strategies within the six PPDMDPP goal areas. Suggesters should refer to the FY 2027 PPA 7721 Implementation Plan, for details about the strategies and objectives for each goal area. Program Objectives: PPDMDPP funds projects focused on critical needs and opportunities to prevent against, detect, and mitigate invasive plant pests and diseases. PPDMDPP projects are organized around six goal areas: Plant Pest and Disease Survey and Analysis Domestic Inspection Pest Identification and Diagnostic Technology Protecting Nursery Production Public Outreach and Education Pest Mitigation and Rapid Response Expected Outcomes: Projects funded under this announcement are expected to support activities that will protect U.S. specialty crops, nursery systems, forestry, and other agricultural production and natural resources from harmful and exotic plant pests and pathogens by improving early plant pest detection, threat identification, and mitigation capabilities. Funding Priorities: PPA 7721’s PPDMDPP funds projects focused on critical needs and opportunities to prevent against, detect, and mitigate invasive plant pests and diseases organized around six goal areas. These six goal areas represent the Program’s funding priorities and include: enhancing plant pest and disease survey and analysis; targeting domestic inspection; enhancing and strengthening pest identification and technology; safeguarding nursery production; conducting targeted outreach and education; and enhancing mitigation and rapid response capabilities (see FY 2027 Implementation Plan). Suggesters must complete a single PPA 7721 ServiceNow Suggestion Submission form per suggestion that provides details on all aspects of the project. The PPA 7721 ServiceNow Suggestion Submission form is available through the PPA 7721 ServiceNow Suggestion Submission portal. Suggesters must include a completed Budget, Survey, or Diagnostic Laboratory template, and Narrative Report (if applicable) as an uploaded document with the form. Refer to the PPA 7721 ServiceNow Suggestion Submission Guidance for more information about submitting suggestions to the PPA 7721 ServiceNow Suggestion Submission portal.
Natural Resources Conservation Service
The purpose of the Feral Swine Eradication and Control Project (FSCP) is to respond to the threat feral swine pose to agriculture, native ecosystems, and human and animal health. Feral swine are a destructive, non-native, invasive species and their populations have expanded across the United States since the 1980’s. Over an estimated $3.4 billion in damage, including agricultural, is caused by feral swine each year. The species can have significant negative impacts on plant and animal habitats, soils, water quality, as well as other natural and cultural resources. Livestock and humans are also susceptible to diseases carried by feral swine. The Agriculture Improvement Act of 2018 directs the United States Department of Agriculture (USDA) to carry out the pilot program where the Secretary has determined that feral swine have been identified as such a threat and the One Big Beautiful Bill Act extended this authority. FSCP funding will be available for projects identified by USDA in conjunction with State Technical Committees in states determined by the Animal and Plant Health Inspection Service (APHIS) Wildlife Services as having high feral swine densities. Please visit the Feral Swine Eradication and Control Pilot Program webpage (https://www.nrcs.usda.gov/feral-swine-eradication-and-control-pilot-program) to find the proposed pilot projects looking for applicants. Additional information about proposed pilot project activities in the following states Alabama, Arkansas, California, Florida, Georgia, Hawaii, Louisiana, Mississippi, Missouri, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas will also be available on the webpage. Pilot projects will consist broadly of three coordinated components: 1) feral swine removal by APHIS, 2) restoration efforts supported by NRCS or non-federal partner, and 3) assistance to producers for feral swine control provided through grants with non-federal partners. This call for proposals is intended to address component 2 and component 3 described above for non-federal partners to provide landowner assistance for restoration and/or on-farm trapping efforts and provide related services as part of the pilot projects described above. Funding for these services will be provided through grant agreements between partners and NRCS. All projects will be a collaborative and coordinated effort between the selected partner, NRCS, and APHIS. It is required that APHIS maintains operational control of feral swine management activities. A webinar for NRCS' Feral Swine Eradication and Control Pilot Program 2026 is scheduled for July 29, 2026 3-4 p.m. Eastern Time and August 20, 2026 3-4 p.m. Eastern Time.
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have significant impact on the treatment and management of a disease or condition addressed in one of the congressionally directed FY26 PRMRP topic areas and FY26 PRMRP strategic goals. Distinctive Features: Must support a clinical trial. Supports two different application categories, based on the phase of planning for the clinical trial: Clinical Trial Only or Clinical Trial with Planning Phase. The Clinical Trial with Planning Phase option is intended to support the final phase of regulatory activities and planning activities that are necessary to be completed prior to initiation of the clinical trial. The planning phase cannot be used to finalize the intervention or support animal studies. Applications that already have regulatory approvals in place and are submitting to the Clinical Trial Only option may be prioritized over those requesting the Planning Phase option. Animal studies are not supported. Studies must complete all preclinical empirical laboratory work prior to the award start date. Supports three funding levels, each offered with and without a Planning Phase: Funding Level 1: Supports phase 0 or phase 1 clinical trials or non-phased trials with fewer than 100 participants. Funding Level 2: Supports phase 2 clinical trials or non-phased trials with fewer than 300 participants. Funding Level 3: Supports phase 3 clinical trials or non-phased trials with more than 300 participants. Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $94.5M to fund approximately 9 Clinical Trial Award applications with total cost caps of $800,000 for the planning phase of a Clinical Trial with Planning Phase, $6M for Funding Level 1, $10M for Funding Level 2, and $20M for Funding Level 3 per award. The maximum period of performance is 4 years for the clinical trial, and 12 months for the planning phase. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Platform Clinical Translation Award supports the translational development and/or early-phase clinical trials for broadly applicable clinical technologies that will address urgent and complex needs related to two congressionally directed FY26 PRMRP topic areas. The platform product in development should address one of the FY26 PRMRP portfolio-specific strategic goals and address the health care needs of military Service Members, Veterans and their Families. Distinctive Features: Allows for multiple Principal Investigators (PIs). The proposed experiments may represent a single project led by a single PI, or it may consist of partnerships between principal investigators that will occur synergistically to advance a platform product. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. Up to two additional PIs can be identified as Partnering PIs. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). Requires a PI-convened external advisory board with patient advocate participation. The patient advocate must be a person living with, or a family member or caretaker of someone with, a disease or condition addressed in one of the applicant-selected congressionally directed FY26 PRMRP topic areas. Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $30M to fund approximately two Platform Clinical Translation Award applications with total cost caps of $15M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with a maximum of $8M in FY26, with the remaining budget to be funded out of future fiscal years depending upon meeting performance-based milestones and availability of future funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Scholar Award (NFRA-SA) supports early-career independent investigators (Scholars) joining the Neurofibromatosis Research Academy to pursue a neurofibromatosis project that may include basic, translational, and/or clinical research. The proposed research should address at least one of the FY26 NFRP Areas of Emphasis, under the leadership of the NFRA Director and Deputy Director. The overarching goal of the NFRA is to conduct innovative and impactful research in the field of neurofibromatosis disorders while developing successful, highly productive NF researchers in a collaborative research and career development environment. Distinctive Features: • Scholar: The Scholar, named as the Principal Investigator, must be less than 10 years of completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave). • Career Guide: This award mechanism requires each Scholar to designate a Career Guide for guidance. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, the application must identify a secondary Career Guide at the Scholar’s institution.
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Synergistic Idea Award (SIA) supports new ideas that represent synergistic approaches to neurofibromatosis (NF) research involving two or three Principal Investigators (PIs). These investigators should utilize their complementary and synergistic perspectives to address a central problem or question in NF research. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project. Distinctive Features: • Partnering Principal Investigators: One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. An additional one or two PI(s) will be identified as a Partnering PI. Each partner will be recognized as a PI, submit a separate application (even if the partners are at the same organization), and receive an individual award.
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award (IIRA) supports high-impact research that addresses a critical need and has the potential to make important contributions to the field of neurofibromatosis disorders or advance patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project. Distinctive Features: This award mechanism offers two funding levels based on participation in two optional features: • Open Science Initiative: Catalyzes research for neurofibromatosis through early access to data and data sharing within the neurofibromatosis community. • Optional Qualified Collaborator: Encourages collaborative research between basic scientists and clinical researchers, and between academic and biotechnology scientists. The funding levels are defined as follows: • Level 1: Applications without an optional feature. • Level 2: Applications including one of the optional features.
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. Distinctive Features: • Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities. • Preliminary Data: Preliminary and/or published data is encouraged but not required.
National Energy Technology Laboratory
Advancing Oil and Natural Gas Production and Delivery This Notice of Funding Opportunity (NOFO) is seeking proposals to advance cost-effective technologies for improving the efficiency, reliability, and resilience of the Unites States oil and natural gas supply chain. This funding opportunity spans research and development efforts focused on enhancing resource utilization, modernizing infrastructure, and accelerating digital transformation within the sector.
Department of Health Care Access and Information
The Song-Brown program funds institutions that train primary care health professionals to provide healthcare in California’s medically underserved areas. This grant opportunity will result in funding organizations to train certified nurse midwifery students to work in underserved communities. Such strategies shall incorporate the following elements: 1. Establishing procedures to identify, recruit, and admit certified nurse midwifery students who possess characteristics which would suggest a predisposition to practice in areas of unmet need, and who express a commitment to serve in areas of unmet need. 2. Implementing counseling and placement programs to encourage training program graduates to enter practice in areas of unmet need. 3. Providing a preceptorship experience in an area of unmet need to enhance the potential of training program graduates to practice in such an area.
Department of Health Care Access and Information
The Song-Brown program funds institutions that train primary care health professionals to provide healthcare in California’s medically underserved areas. This grant opportunity will result in funding organizations to train primary carenurse practitioners and physician assistant trainees to work in underservedcommunities. Such strategies shall incorporate the following elements: 1. Establishing procedures to identify, recruit and admit primary care nursepractitioner and physician assistant trainees who possess characteristicswhich would suggest a predisposition to practice in areas of unmet need, andwho express a commitment to serve in areas of unmet need. 2. Implementing counseling and placement program to encourage trainingprogram graduates to enter practice in areas of unmet need. 3. Providing a preceptorship experience in an area of unmet need to enhancethe potential of training program graduates to practice in such an area.
Bureau of Justice Assistance
This is a notice of funding opportunity (NOFO) for the BJA FY2026 Harold Rogers Prescription Drug Monitoring Program (PDMP). This opportunity seeks to enhance the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized agency. PDMPs help state and local governments to detect and prevent the diversion and abuse of pharmaceutically controlled substances such as opioids and other prescription drugs. The primary function of a PDMP is to facilitate the collection, analysis, and reporting of information on the prescribing, dispensing, and use of prescription drugs with a state, commonwealth, district, or territory. The goal of the Harold Rogers PDMP is to strengthen states’ and territories’ ability to maintain and enhance their existing PDMPs by accommodating local decision-making based on state laws and preferences and replicating promising practices. As part of supporting the enhancement of PDMPs, the Harold Rogers PDMP supports the integration of PDMP data with health information exchanges, electronic health records, or pharmacy dispensing systems, including engaging with tribal entities and rural areas where integration rates may be lower. This program helps to break the cycle of drug addiction and violence by reducing the demand, use, and the illegal trafficking of controlled substances.
Environmental Protection Agency
This notice announces the availability of funds and solicits applications from eligible entities to deliver Brownfields Job Training programs that recruit, train, and place local, unemployed, and underemployed residents with the skills needed to secure full-time employment in the environmental field. Brownfields Job Training Grants fund training programs that strengthen local workforces by preparing program graduates for environmental jobs that support cleanup and revitalization efforts in their own communities. Training may include a range of brownfield-related environmental skills such as the assessment and cleanup of solid and hazardous waste; chemical risk management; stormwater management relating to site cleanup; planning and site preparation for low-impact development activities; site preparation for green infrastructure installation; and vulnerability assessment and contamination mitigation planning. Please carefully review Section 4.E. of these guidelines, Section IV of EPA NOFO Clauses, and the Frequently Asked Questions, which can be found at https://www.epa.gov/brownfields/frequently-asked-questions-about-brownfields-job-training-jt-grants. A checklist of required application forms and documents is in Section 4.A. For the purposes of these guidelines, the term “grant” refers to the cooperative agreement that EPA will award to a successful applicant. In this Notice of Funding Opportunity (NOFO), “Project” refers to the applicant’s proposed Brownfields Job Training effort to be funded under this competition. Unless otherwise noted, “training program” is used synonymously with “project.”
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s disease related dementia (AD/ADRD) and their care partner(s). Distinctive Features: Clinical research and clinical trials are allowed; however, clinical trials solely testing or evaluating pharmacological interventions do not meet the intent of this funding opportunity. Studies utilizing animal models do not meet the intent of the mechanism and are not allowed. Preliminary data are required. Community collaboration is required for research prospectively enrolling human subjects. The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged. Career Initiation or Transition (CIT) Partnership Option: The TrCA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining a diagnosis, meaningful disease monitoring and accurate prognosis. Distinctive Features: Clinical research is allowed, however clinical trials and animal research are prohibited. Preliminary data are required. Community collaboration is required for studies prospectively enrolling human subjects. Study Population: The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged. Career Initiation or Transition (CIT) Partnership Option: The TrDA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD). Distinctive Features: • Applications must address at least one of the following focus areas: ○ Risk Factor Knowledge: Research that advances understanding, identification, and/or validation of risk and/or protective factors, with research outcomes/products focused on accelerating solutions. Projects may include, but are not limited to, research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks not listed here. ○ Risk Reduction Solutions: Research that describes methods, technologies, and strategies that contribute to reducing risk and preventing AD/ADRD. • Clinical research is allowed, however clinical trials and animal research are prohibited. • Preliminary data are required. • Community collaboration is required for research prospectively enrolling human subjects. • Career Initiation or Transition (CIT) Partnership Option: The TrRA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.
Strategic Growth Council
The Community Resilience Centers Program (CRC) funds planning, development, construction, and upgrades of local facilities to serve as Community Resilience Centers, providing shelter and resources during climate and other emergencies. The program will also fund ongoing year-round community services and programs that build overall community resilience. CRC Implementation Grants will fund new construction and upgrades of CRC Facilities and Campus Amenities that support use of the CRC Facility. Additionally, Implementation Grants fund programs and services that build social cohesion and community resilience. In addition to advancing general program objectives Implementation Grant activities include pre-development, community engagement, construction, services and programs, and evaluation. Eligible implementation activities include: - Pre-Development Phase: pre-construction activities such as facility condition assessments, planning, engineering, architectural, and other design work, and soft costs for construction plans. - CRC Facility Construction and Retrofits: Activities related to direct construction, retrofits, and other upgrades to the CRC Facility itself. - Campus Amenities: Activities related to construction or improvements to amenities located at the CRC Facility that strengthen the local community’s resilience to climate and other disasters. - Community Resilience Services and Programs: Services and programs that operate out of the CRC Facility that build community resilience and encourage year-round use of the CRC Facility. - Partner Sites: Site(s) managed by Applicants that offers programming and services that advance resilience within the community. Each CRC Implementation Grant application must include at least two Partners with at least one being a community-based organization (CBO), if the Lead Applicant is not already a CBO. The Lead Applicant and Partners will submit a signed Collaborative Governance Worksheet and letters of commitment at application. Application Technical Assistance (Application TA) is available during the application period for eligible applicants. CRC will prioritize Tribal applicants for Application TA. Application TA may be available for additional applicants on a case-by-case basis. If you are interested in Application TA, complete the Application TA Request Form by July 31, 2026: https://forms.cloud.microsoft/g/2aSjd31Y7E
Employment and Training Administration
The Employment and Training Administration (ETA) intends to award a cooperative agreement to the National Association of State Workforce Agencies' Center for Employment Security Education and Research (NASWA/CESER) for continued operations of the Unemployment Insurance (UI) Integrity Center of Excellence (Integrity Center). The Consolidated Appropriations Act, 2026 (Public Law 119-75) provides Fiscal Year (FY) 2026 funding for federal agencies and provides "... $9,000,000 for continued support of the Unemployment Insurance Integrity Center of Excellence... ." as part of the Department of Labor's appropriation for State Unemployment Insurance and Employment Service Operations. The UI Integrity Center has been operated by the NASWA/CESER since FY 2017. NASWA/CESER is a 501(c)(3) entity incorporated in August 1994 as an education and research arm of the NASWA, which is a national organization of state administrators of the publicly-funded state workforce system and is a leading provider of information technology, education, and research support focused exclusively on UI and workforce development initiatives and activities. The primary mission of the UI Integrity Center is to provide training and technical assistance to states to improve UI program integrity; develop and disseminate UI program integrity resources and promote innovative new tools and products that are transferable and scalable for all states to prevent UI improper payments and enhance fraud prevention solutions; and enable rapid alerts to states on new improper payment practices and fraud schemes as they are identified.
National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on developing a comprehensive and cohesive understanding of cancer metastasis. Towards this goal, the NCI will support U54 Specialized Centers that together will continue to serve as the hub of the Metastasis Research Network (MetNet). Each MetNet Center should propose an overarching scientific theme that will be pursued through two or three scientific inter- and multidisciplinary basic research projects. The projects should use integrative system level approaches to elucidate and integrate a mechanistic understanding of the non-linear, dynamic, and emergent processes in metastasis. Overarching themes should encompass the interplay between at least two central elements in the metastatic process such as early dissemination, cellular, soluble and/or physical microenvironment crosstalk, dormancy, or mechanisms of responses by metastatic cells to therapies. Studies on all types of cancer are welcome, including rare and pediatric metastatic cancers.Research proposed by MetNet Centers is expected to advance our understanding towards a more comprehensive appreciation of metastasis as a whole body, systems-level problem.